BCIDP Board Certified Infectious Disease Pharmacist Exam Practice Test
Build your confidence for BCIDP Board Certified Infectious Disease Pharmacist Exam. Practice the concepts, understand the answers, and strengthen your knowledge one question at a time.
Try a sample questionExam overview and details
The Board Certified Infectious Diseases Pharmacist (BCIDP) credential is the premier certification validating specialized expertise in antimicrobial stewardship, infection prevention, and the pharmacotherapy of complex infectious diseases. Awarded by the Board of Pharmacy Specialties (BPS), this certification signifies that a pharmacist has demonstrated the advanced knowledge and clinical judgment required to optimize patient outcomes in infectious disease management. BCIDP-certified pharmacists are recognized leaders in developing and implementing antimicrobial stewardship programs (ASPs), managing infections in immunocompromised hosts, interpreting diagnostic microbiology, and navigating the challenges of antimicrobial resistance. This credential is essential for pharmacists practicing in acute care, academia, public health, and research who are responsible for guiding evidence-based antimicrobial use, reducing healthcare-associated infections, and contributing to the global fight against multidrug-resistant organisms. Achieving BCIDP status distinguishes a pharmacist as a top-tier expert, directly impacting patient safety, institutional quality metrics, and public health initiatives.
Sample Questions
Choose an answer and explore the explanation to see how practice works.
A 71-year-old with Enterococcus faecalis native-valve endocarditis has an isolate susceptible to ampicillin and ceftriaxone synergy. Baseline creatinine clearance is 32 mL/min, and the team proposes ampicillin plus gentamicin for 6 weeks. Which regimen best reduces toxicity while preserving synergy?
A patient with hospital-acquired pneumonia has Acinetobacter baumannii-calcoaceticus complex resistant to carbapenems and susceptible to sulbactam-durlobactam. The team asks why the regimen includes sulbactam rather than tazobactam. Which explanation is best?
A 59-year-old with acute myeloid leukemia has febrile neutropenia, hypotension, and a history of ESBL Klebsiella bacteremia 2 months ago. He is taking levofloxacin prophylaxis. There is no catheter erythema, pneumonia, or skin infection. Which empiric approach is most appropriate while cultures are pending?
A ranch worker with a prosthetic valve has months of fevers, negative routine blood cultures, hepatitis, and serology strongly positive for Coxiella burnetii phase I IgG. Which epidemiologic and diagnostic point is most relevant?
A 72-year-old with severe community-acquired pneumonia is started on ceftriaxone plus azithromycin. Two hours later, urine Legionella antigen is positive. QTc is 535 ms, potassium is 3.1 mEq/L, and he takes amiodarone. Which pharmacist recommendation best balances efficacy and safety?
Career Opportunities & Salary
Exam insights and study advice
Earning the BCIDP credential is a definitive career milestone that establishes your authority in a critical and rapidly evolving specialty. It provides formal, industry-wide recognition of your advanced competencies, setting you apart in a competitive job market. This certification is increasingly required or preferred for leadership roles in antimicrobial stewardship programs, infectious disease consult services, and clinical coordinator positions. It validates your expertise to hospital administrators, healthcare teams, and patients, enhancing your professional credibility and influence in shaping institutional protocols and national guidelines. For the pharmacy profession, BCIDP certification elevates the standard of care in infectious diseases and demonstrates the indispensable role of pharmacists in improving antimicrobial use and combating resistance.
What this exam covers
Use the published domain weights to plan your study. Practice results do not predict your certification exam score.
01Therapeutics and Patient Management
This domain focuses on clinical decision-making and patient care strategies, representing 60.0% of the exam, which makes it the primary area of assessment for candidates seeking to demonstrate their professional expertise in pharmacy.
02Professional Practice
This domain addresses the professional responsibilities and practice standards required of an infectious disease pharmacist, comprising 22.0% of the overall examination content to ensure high quality care for all patients in clinical settings.
03Pathophysiology and Epidemiology of Infections
This domain covers the biological mechanisms of infections and the important patterns of disease spread within populations, accounting for exactly 18.0% of the total exam content for all candidates seeking certification.